![Microfluidic Antibody Affinity Profiling Reveals the Role of Memory Reactivation and Cross-Reactivity in the Defense Against SARS-CoV-2 | ACS Infectious Diseases Microfluidic Antibody Affinity Profiling Reveals the Role of Memory Reactivation and Cross-Reactivity in the Defense Against SARS-CoV-2 | ACS Infectious Diseases](https://pubs.acs.org/cms/10.1021/acsinfecdis.1c00486/asset/images/medium/id1c00486_0002.gif)
Microfluidic Antibody Affinity Profiling Reveals the Role of Memory Reactivation and Cross-Reactivity in the Defense Against SARS-CoV-2 | ACS Infectious Diseases
![Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen: Molecular Therapy Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen: Molecular Therapy](https://www.cell.com/cms/attachment/44330896-4245-4dcf-9bb4-ac9c48dc327b/gr1_lrg.jpg)
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen: Molecular Therapy
![Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response | Science Advances Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response | Science Advances](https://www.science.org/cms/10.1126/sciadv.abq8276/asset/fc449466-b0fe-4d9b-882b-c2773408575c/assets/images/large/sciadv.abq8276-f1.jpg)
Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response | Science Advances
![Spherical Neutralizing Aptamer Inhibits SARS-CoV-2 Infection and Suppresses Mutational Escape | Journal of the American Chemical Society Spherical Neutralizing Aptamer Inhibits SARS-CoV-2 Infection and Suppresses Mutational Escape | Journal of the American Chemical Society](https://pubs.acs.org/cms/10.1021/jacs.1c08226/asset/images/medium/ja1c08226_0004.gif)